Supplementary Methods and legends for Supplementary tables and figures
Kaplan Meier overall survival curves by PIK3CA, CDKN2A and TP53 allelic mutation state
Phasing data for two tumors with bi-allelic TP53 mutations
Zygosity estimates for the MCT samples by group
PDX Response to Standard Therapy
Histologic diagnoses for all tumors implanted (WHO grade II-IV)
Figures S1-S8, Supplementary Methods, Supplementary Bibliography
A list of the 151 genes included in the Agilent Comprehensive Cancer Panel
Quality Control parameters on all sequenced samples
Raw copy number alterations for all genes in all samples
Quantitative PCR results for high risk HPV genotypes
Copy Number Alterations identified in SCC and MCT samples
A list of genes analysed for copy number state
Molecular subtype, MGMT methylation, expressed fusions
Patient characteristics of viable PDX lines
Frequency of genomic alterations in PDX compared to TCGA
A full list of mutations identified in SCC and MCT samples
Copy number profiles of MCT samples.
Short tandem repeat genotype and PDX growth characteristics
Concordance of alterations in cases with multiple SCC samples